GLP-1 drugs cost-effective for knee osteoarthritis and obesity Save Analysis led by Mass General Brigham researchers shows tirzepatide offers greater value than semaglutide for most patients For eligible and willing patients, bariatric surgery provides the best option from a clinical and economic perspective A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for people with knee osteoarthritis and obesity, with tirzepatide providing greater health benefits at lower cost compared to semaglutide
The I, Hannigan GE, Cowley GS, Reginald S, Zhong Y, Gusella JF, et al
Getting Semaglutide In-Person in Tennessee Tennessees major cities have genuine in-person options, though availability varies considerably once you move outside them
Users on the pyridoxine compound often report a smoother transition, with milder and shorter-duration nausea episodes
Kim MH, Kim EH, Jung HS, Yang D, Park EY, Jun HS
